Epidemiology of ventilator associated pneumonia in ICU COVID 19 patients: an alarming high rate of multidrug resistant bacteria Journal of Anesthesia, Analgesia and Critical Care Springer Nature Link Clinical and economic consequences of : Critical Care Medicine VENTILATOR = LIFE SUPPORT but also VAP RISK. Up to 20% of ventilated patients >48 hrs develop VAP. Mortality? Can reach 50%. Here's what actually matters in ICU rounds Full article: The association between neonatal mortality and ventilator association pneumonia Mortality, incidence, and microbiological documentation of ventilated acquired pneumonia (VAP) in critically ill patients with COVID 19 or influenza ScienceDirect